APA

Delaugerre C., Mouroux M., Yvon-Groussin A., Simon A., Angleraud F., Huraux J. M., Agut H., Katlama C. & Calvez V. (20010510). Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice. : Antimicrobial agents and chemotherapy.

Chicago

Delaugerre C, Mouroux M, Yvon-Groussin A, Simon A, Angleraud F, Huraux J M, Agut H, Katlama C and Calvez V. 20010510. Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice. : Antimicrobial agents and chemotherapy.

Harvard

Delaugerre C., Mouroux M., Yvon-Groussin A., Simon A., Angleraud F., Huraux J. M., Agut H., Katlama C. and Calvez V. (20010510). Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice. : Antimicrobial agents and chemotherapy.

MLA

Delaugerre C, Mouroux M, Yvon-Groussin A, Simon A, Angleraud F, Huraux J M, Agut H, Katlama C and Calvez V. Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice. : Antimicrobial agents and chemotherapy. 20010510.